News

XD technology is an intensified cell culture process with typical XD titer improvement of 8-10 times and is applicable for multiple biological products such as proteins, fusion proteins

The secondary antibody reagent is designed to eliminate the interference that interferes with IP experiments when the IP and western blot primary antibodies are from the same host.

Made with botanicals and other natural ingredients, Think functional drink is citrus flavored and contains no added sugar. Solixir founder Scott Lerner said the company created Think as

A 9mg dose tablet is approved for administration once a day in adult patients with ulcerative colitis for up to eight weeks. The company anticipates launching Uceris, indicated

NovAliX will employ its biophysical capabilities and medicinal chemistry potential in producing the lead candidates. NovAliX president Stephan Jenn said, "This drug discovery collaboration with a leading Japanese

The new facilities will double the current pharmaceutical development capacity. The new non-GMP formulation development facility will provide clients with greater flexibility and speed in formulation and process

The extended-release liquid methylphenidate is indicated for the treatment of ADHD in patients from six years of age by administering once a day. Pfizer emerging markets and established

According to the deal, PharmAthene will use the technology in the production of recombinant butyrylcholinesterase (rBChE) bioscavenger. rBChE absorbs toxins including organophosphorous compounds and certain pesticides with the

The NOA, which is issued based on patent application13/610,217, includes claims for using icosapent ethyl, or EPA, including Vascepa, in lowering triglycerides through the daily administration of about